P4HA1, a Prognostic Biomarker that Correlates With Immune Infiltrates in Lung Adenocarcinoma and Pan-Cancer
Objective: Prolyl 4-hydroxylase, alpha polypeptide I (P4HA1), a key enzyme in collagen synthesis, comprises two identical alpha subunits and two beta subunits. However, the immunomodulatory role of P4HA1 in tumor immune microenvironment (TIME) remains unclear. This study aimed to evaluate the progno...
Main Authors: | Qi Zhao, Junfeng Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-12-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.754580/full |
Similar Items
-
ISYNA1: An Immunomodulatory-Related Prognostic Biomarker in Colon Adenocarcinoma and Pan-Cancer
by: Zeming Jia, et al.
Published: (2022-02-01) -
AP3S1 is a Novel Prognostic Biomarker and Correlated With an Immunosuppressive Tumor Microenvironment in Pan-Cancer
by: Gujie Wu, et al.
Published: (2022-07-01) -
HILPDA Is a Prognostic Biomarker and Correlates With Macrophage Infiltration in Pan-Cancer
by: Chengdong Liu, et al.
Published: (2021-03-01) -
DHRS7 is an immune-related prognostic biomarker of KIRC and pan-cancer
by: Sheng Tang, et al.
Published: (2022-10-01) -
I kappa B kinase interacting protein as a promising biomarker in pan-cancer: A multi-omics analysis
by: Chenyang Bi, et al.
Published: (2023-03-01)